HCP, Inc. (HCP) traded negative at $30.04. On an intraday basis, the price dropped -0.28 points or -0.92%. The composite uptick value was $25.84 million while the combined downtick value was $16.26. The net money flow was $9.58 million while the up/down ratio was not very comforting at 1.59. The shares on a weekly note has seen a change in share price of 1.62%.According to the trading data, the shares saw a block trade with $9.4 million in upticks and $0.35 million in downticks. The up/down ratio for the block was calculated to be 26.87. The net money flow for the block trade was 9.05.Block trades are executed by Investment Banking firms or Wealth Managers shifting positions or Day traders taking advantage of trading signals.
Shares of HCP, Inc. rose by 0.54% in the last five trading days and 1.08% for the last 4 weeks. HCP, Inc. has dropped 2.5% during the last 3-month period . Year-to-Date the stock performance stands at 1.08%. HCP, Inc. (NYSE:HCP) witnessed a decline in the market cap on Wednesday as its shares dropped 0.92% or 0.28 points. After the session commenced at $30.33, the stock reached the higher end at $30.63 while it hit a low of $29.81. With the volume soaring to 5,473,939 shares, the last trade was called at $30.04. The company has a 52-week high of $36.50149. The company has a market cap of $14,058 million and there are 467,971,170 shares in outstanding. The 52-week low of the share price is $22.670468.
Company has reported several Insider transactions to the SEC, on Jan 31, 2017, Thomas Klaritch (Senior Managing Director) sold 16,519 shares at 40.15 per share price.On Sep 8, 2016, Thomas D Kirby (Executive Vice President) sold 3,000 shares at 40.24 per share price.On Sep 1, 2016, Darren A Kowalske (Executive Vice President) sold 2,250 shares at 39.20 per share price.
HCP Last issued its quarterly earnings results on Nov 1, 2016. The company reported $0.72 EPS for the quarter, beating the analyst consensus estimate by $ 0.01. Analyst had a consensus of $0.71.Analysts expectations of $ 626.34.During the same quarter in the previous year, the company posted $0.79 EPS.
Several Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock.HCP was Upgraded by Goldman to Buy on Jan 25, 2017. HCP was Resumed by Barclays on Jan 5, 2017 to Equal Weight, Price Target of the shares are set at $32.HCP was Upgraded by Mizuho on Nov 21, 2016 to Buy, Price Target of the shares are set at $32.HCP was Upgraded by RBC Capital Mkts on Nov 4, 2016 to Sector Perform, Lowers Price Target to $ 30 from a previous price target of $35 .
Health Care Property Investors, Inc. is a real estate investment trust. The company invests in health care related real estate located throughout the United States, including long-term care facilities, congregate care and assisted living facilities, acute care and rehabilitation hospitals, medical office buildings, physician group practice clinics and psychiatric facilities.